TRIM21 and systemic lupus erythematosus: Their localization is mainly cytoplasmic, and the increased expression of Ro52 in SS and SLE patients is probably implicated positively or negatively in the alteration of cellular immune responses and in the increased apoptosis observed in primary SS patients.